APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antidiuretic Hormone (ADH)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antidiuretic Hormone (ADH) Market Outlook and Growth Opportunities 2026

Report ID 173966140422 December 2025191 pages

Choose your research edition.

Industry ResearchAntidiuretic Hormone (ADH) Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Antidiuretic Hormone (ADH) Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Antidiuretic Hormone (ADH) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antidiuretic Hormone (ADH) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Antidiuretic Hormone (ADH) Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Antidiuretic Hormone (ADH) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antidiuretic Hormone (ADH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antidiuretic Hormone (ADH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antidiuretic Hormone (ADH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antidiuretic Hormone (ADH) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antidiuretic Hormone (ADH) market include Shanghai Soho-Yiming Pharmaceuticals, Novartis, Pfizer, Ferring Pharmaceuticals, Fresenius Kabi, Par Pharmaceutical and Astellas Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Antidiuretic Hormone (ADH) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antidiuretic Hormone (ADH) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antidiuretic Hormone (ADH) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Antidiuretic Hormone (ADH) market.

Antidiuretic Hormone (ADH) Segment by Company

Shanghai Soho-Yiming Pharmaceuticals

Novartis

Pfizer

Ferring Pharmaceuticals

Fresenius Kabi

Par Pharmaceutical

Astellas Pharma

Antidiuretic Hormone (ADH) Segment by Type

Subcutaneous Injection

Intravenous Injection

Intramuscular Injection

Antidiuretic Hormone (ADH) Segment by Application

Vasodilatory Shock

Gastrointestinal Bleeding

Ventricular Tachycardia & Fibrillation

Anti-Diuretic Hormone Deficiency

Antidiuretic Hormone (ADH) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Antidiuretic Hormone (ADH) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Antidiuretic Hormone (ADH) key companies, revenue, market share, and recent developments.

3. To split the Antidiuretic Hormone (ADH) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Antidiuretic Hormone (ADH) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antidiuretic Hormone (ADH) significant trends, drivers, influence factors in global and regions.

6. To analyze Antidiuretic Hormone (ADH) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidiuretic Hormone (ADH) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antidiuretic Hormone (ADH) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidiuretic Hormone (ADH).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antidiuretic Hormone (ADH) industry.

Chapter 3: Detailed analysis of Antidiuretic Hormone (ADH) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Antidiuretic Hormone (ADH) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Antidiuretic Hormone (ADH) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antidiuretic Hormone (ADH) Industry Trends Table 2. Antidiuretic Hormone (ADH) Industry Drivers Table 3. Antidiuretic Hormone (ADH) Industry Opportunities and Challenges Table 4. Antidiuretic Hormone (ADH) Industry Restraints Table 5. Global Antidiuretic Hormone (ADH) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antidiuretic Hormone (ADH) Revenue Share by Company (2021-2026) Table 7. Global Antidiuretic Hormone (ADH) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Antidiuretic Hormone (ADH) Key Company Manufacturing Base & Headquarters Table 9. Global Antidiuretic Hormone (ADH) Company, Product Type & Application Table 10. Global Antidiuretic Hormone (ADH) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Antidiuretic Hormone (ADH) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Subcutaneous Injection Table 15. Significant Companies of Intravenous Injection Table 16. Significant Companies of Intramuscular Injection Table 17. Global Antidiuretic Hormone (ADH) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Antidiuretic Hormone (ADH) Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Antidiuretic Hormone (ADH) Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Antidiuretic Hormone (ADH) Sales Value Share by Type (2021-2026) Table 21. Global Antidiuretic Hormone (ADH) Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Vasodilatory Shock Table 23. Significant Companies of Gastrointestinal Bleeding Table 24. Significant Companies of Ventricular Tachycardia & Fibrillation Table 25. Significant Companies of Anti-Diuretic Hormone Deficiency Table 26. Global Antidiuretic Hormone (ADH) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Antidiuretic Hormone (ADH) Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Antidiuretic Hormone (ADH) Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Antidiuretic Hormone (ADH) Sales Value Share by Application (2021-2026) Table 30. Global Antidiuretic Hormone (ADH) Sales Value Share by Application (2027-2032) Table 31. Global Antidiuretic Hormone (ADH) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Antidiuretic Hormone (ADH) Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Antidiuretic Hormone (ADH) Sales Value Share by Region (2021-2026) Table 34. Global Antidiuretic Hormone (ADH) Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Antidiuretic Hormone (ADH) Sales Value Share by Region (2027-2032) Table 36. Global Antidiuretic Hormone (ADH) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Antidiuretic Hormone (ADH) Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Antidiuretic Hormone (ADH) Sales Value Market Share by Country (2021-2026) Table 39. Global Antidiuretic Hormone (ADH) Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Antidiuretic Hormone (ADH) Sales Value Market Share by Country (2027-2032) Table 41. Shanghai Soho-Yiming Pharmaceuticals Company Information Table 42. Shanghai Soho-Yiming Pharmaceuticals Business Overview Table 43. Shanghai Soho-Yiming Pharmaceuticals Antidiuretic Hormone (ADH) Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Shanghai Soho-Yiming Pharmaceuticals Antidiuretic Hormone (ADH) Product Portfolio Table 45. Shanghai Soho-Yiming Pharmaceuticals Recent Development Table 46. Novartis Company Information Table 47. Novartis Business Overview Table 48. Novartis Antidiuretic Hormone (ADH) Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Novartis Antidiuretic Hormone (ADH) Product Portfolio Table 50. Novartis Recent Development Table 51. Pfizer Company Information Table 52. Pfizer Business Overview Table 53. Pfizer Antidiuretic Hormone (ADH) Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Pfizer Antidiuretic Hormone (ADH) Product Portfolio Table 55. Pfizer Recent Development Table 56. Ferring Pharmaceuticals Company Information Table 57. Ferring Pharmaceuticals Business Overview Table 58. Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Product Portfolio Table 60. Ferring Pharmaceuticals Recent Development Table 61. Fresenius Kabi Company Information Table 62. Fresenius Kabi Business Overview Table 63. Fresenius Kabi Antidiuretic Hormone (ADH) Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Fresenius Kabi Antidiuretic Hormone (ADH) Product Portfolio Table 65. Fresenius Kabi Recent Development Table 66. Par Pharmaceutical Company Information Table 67. Par Pharmaceutical Business Overview Table 68. Par Pharmaceutical Antidiuretic Hormone (ADH) Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Par Pharmaceutical Antidiuretic Hormone (ADH) Product Portfolio Table 70. Par Pharmaceutical Recent Development Table 71. Astellas Pharma Company Information Table 72. Astellas Pharma Business Overview Table 73. Astellas Pharma Antidiuretic Hormone (ADH) Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Astellas Pharma Antidiuretic Hormone (ADH) Product Portfolio Table 75. Astellas Pharma Recent Development Table 76. Research Programs/Design for This Report Table 77. Authors List of This Report Table 78. Secondary Sources Table 79. Primary Sources List of Figures Figure 1. Antidiuretic Hormone (ADH) Product Image Figure 2. Global Antidiuretic Hormone (ADH) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antidiuretic Hormone (ADH) Market Size (2021-2032) & (US$ Million) Figure 4. Global Antidiuretic Hormone (ADH) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Subcutaneous Injection Image Figure 8. Intravenous Injection Image Figure 9. Intramuscular Injection Image Figure 10. Global Antidiuretic Hormone (ADH) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Antidiuretic Hormone (ADH) Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Antidiuretic Hormone (ADH) Sales Value Share by Type (2021-2032) Figure 13. Vasodilatory Shock Image Figure 14. Gastrointestinal Bleeding Image Figure 15. Ventricular Tachycardia & Fibrillation Image Figure 16. Anti-Diuretic Hormone Deficiency Image Figure 17. Global Antidiuretic Hormone (ADH) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Antidiuretic Hormone (ADH) Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Antidiuretic Hormone (ADH) Sales Value Share by Application (2021-2032) Figure 20. Global Antidiuretic Hormone (ADH) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Antidiuretic Hormone (ADH) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Antidiuretic Hormone (ADH) Sales Value (2021-2032) & (US$ Million) Figure 23. North America Antidiuretic Hormone (ADH) Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Antidiuretic Hormone (ADH) Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Antidiuretic Hormone (ADH) Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Antidiuretic Hormone (ADH) Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Antidiuretic Hormone (ADH) Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Antidiuretic Hormone (ADH) Sales Value (2021-2032) & (US$ Million) Figure 29. South America Antidiuretic Hormone (ADH) Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Antidiuretic Hormone (ADH) Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Antidiuretic Hormone (ADH) Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Subcutaneous Injection
  • Intravenous Injection
  • Intramuscular Injection
Applications
  • Vasodilatory Shock
  • Gastrointestinal Bleeding
  • Ventricular Tachycardia & Fibrillation
  • Anti-Diuretic Hormone Deficiency
Companies covered
  • Shanghai Soho-Yiming Pharmaceuticals
  • Novartis
  • Pfizer
  • Ferring Pharmaceuticals
  • Fresenius Kabi
  • Par Pharmaceutical
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antidiuretic Hormone (ADH) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antidiuretic Hormone (ADH) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Antidiuretic Hormone (ADH) Market Dynamics
  1. 2.1 Antidiuretic Hormone (ADH) Industry Trends
  2. 2.2 Antidiuretic Hormone (ADH) Industry Drivers
  3. 2.3 Antidiuretic Hormone (ADH) Industry Opportunities and Challenges
  4. 2.4 Antidiuretic Hormone (ADH) Industry Restraints
3 Antidiuretic Hormone (ADH) Market by Company
  1. 3.1 Global Antidiuretic Hormone (ADH) Company Revenue Ranking in 2025
  2. 3.2 Global Antidiuretic Hormone (ADH) Revenue by Company (2021-2026)
  3. 3.3 Global Antidiuretic Hormone (ADH) Company Ranking (2024-2026)
  4. 3.4 Global Antidiuretic Hormone (ADH) Company Manufacturing Base and Headquarters
  5. 3.5 Global Antidiuretic Hormone (ADH) Company Product Type and Application
  6. 3.6 Global Antidiuretic Hormone (ADH) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Antidiuretic Hormone (ADH) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Antidiuretic Hormone (ADH) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Antidiuretic Hormone (ADH) Market by Type
  1. 4.1 Antidiuretic Hormone (ADH) Type Introduction
  2. 4.1.1 Subcutaneous Injection
  3. 4.1.2 Intravenous Injection
  4. 4.1.3 Intramuscular Injection
  5. 4.2 Global Antidiuretic Hormone (ADH) Sales Value by Type
  6. 4.2.1 Global Antidiuretic Hormone (ADH) Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Antidiuretic Hormone (ADH) Sales Value by Type (2021-2032)
  8. 4.2.3 Global Antidiuretic Hormone (ADH) Sales Value Share by Type (2021-2032)
5 Antidiuretic Hormone (ADH) Market by Application
  1. 5.1 Antidiuretic Hormone (ADH) Application Introduction
  2. 5.1.1 Vasodilatory Shock
  3. 5.1.2 Gastrointestinal Bleeding
  4. 5.1.3 Ventricular Tachycardia & Fibrillation
  5. 5.1.4 Anti-Diuretic Hormone Deficiency
  6. 5.2 Global Antidiuretic Hormone (ADH) Sales Value by Application
  7. 5.2.1 Global Antidiuretic Hormone (ADH) Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Antidiuretic Hormone (ADH) Sales Value by Application (2021-2032)
  9. 5.2.3 Global Antidiuretic Hormone (ADH) Sales Value Share by Application (2021-2032)
6 Antidiuretic Hormone (ADH) Regional Value Analysis
  1. 6.1 Global Antidiuretic Hormone (ADH) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antidiuretic Hormone (ADH) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Antidiuretic Hormone (ADH) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Antidiuretic Hormone (ADH) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antidiuretic Hormone (ADH) Sales Value (2021-2032)
  7. 6.3.2 North America Antidiuretic Hormone (ADH) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Antidiuretic Hormone (ADH) Sales Value (2021-2032)
  10. 6.4.2 Europe Antidiuretic Hormone (ADH) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Antidiuretic Hormone (ADH) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Antidiuretic Hormone (ADH) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Antidiuretic Hormone (ADH) Sales Value (2021-2032)
  16. 6.6.2 South America Antidiuretic Hormone (ADH) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Antidiuretic Hormone (ADH) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Antidiuretic Hormone (ADH) Sales Value Share by Country, 2025 VS 2032
7 Antidiuretic Hormone (ADH) Country-level Value Analysis
  1. 7.1 Global Antidiuretic Hormone (ADH) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antidiuretic Hormone (ADH) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Antidiuretic Hormone (ADH) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Antidiuretic Hormone (ADH) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Antidiuretic Hormone (ADH) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Antidiuretic Hormone (ADH) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Antidiuretic Hormone (ADH) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai Soho-Yiming Pharmaceuticals
  2. 8.1.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
  3. 8.1.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
  4. 8.1.3 Shanghai Soho-Yiming Pharmaceuticals Antidiuretic Hormone (ADH) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai Soho-Yiming Pharmaceuticals Antidiuretic Hormone (ADH) Product Portfolio
  6. 8.1.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Antidiuretic Hormone (ADH) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Antidiuretic Hormone (ADH) Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Antidiuretic Hormone (ADH) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Antidiuretic Hormone (ADH) Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Ferring Pharmaceuticals
  20. 8.4.1 Ferring Pharmaceuticals Company Information
  21. 8.4.2 Ferring Pharmaceuticals Business Overview
  22. 8.4.3 Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Product Portfolio
  24. 8.4.5 Ferring Pharmaceuticals Recent Developments
  25. 8.5 Fresenius Kabi
  26. 8.5.1 Fresenius Kabi Company Information
  27. 8.5.2 Fresenius Kabi Business Overview
  28. 8.5.3 Fresenius Kabi Antidiuretic Hormone (ADH) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Fresenius Kabi Antidiuretic Hormone (ADH) Product Portfolio
  30. 8.5.5 Fresenius Kabi Recent Developments
  31. 8.6 Par Pharmaceutical
  32. 8.6.1 Par Pharmaceutical Company Information
  33. 8.6.2 Par Pharmaceutical Business Overview
  34. 8.6.3 Par Pharmaceutical Antidiuretic Hormone (ADH) Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Par Pharmaceutical Antidiuretic Hormone (ADH) Product Portfolio
  36. 8.6.5 Par Pharmaceutical Recent Developments
  37. 8.7 Astellas Pharma
  38. 8.7.1 Astellas Pharma Company Information
  39. 8.7.2 Astellas Pharma Business Overview
  40. 8.7.3 Astellas Pharma Antidiuretic Hormone (ADH) Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Astellas Pharma Antidiuretic Hormone (ADH) Product Portfolio
  42. 8.7.5 Astellas Pharma Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst